Reducing Recurrent Cystitis in Women

Introduction to Treatment Options

The American Urological Association recommends vaginal estrogen replacement as the foundation for postmenopausal women, reducing recurrence by 75% 1
The American College of Obstetricians and Gynecologists suggests starting with vaginal estrogen replacement, which is the most effective non-antimicrobial intervention with strong evidence 2, 3, 1

The North American Menopause Society recommends using estriol cream 0.5 mg intravaginally, ensuring weekly doses of ≥850 µg for optimal efficacy 1, 4
The International Society for the Study of Women's Sexual Health suggests considering adding lactobacillus-containing probiotics to vaginal estrogen for additional benefit 2, 3
The American Geriatrics Society recommends adding methenamine hippurate 1 gram twice daily if recurrences persist despite estrogen 2, 3, 4

The American College of Obstetricians and Gynecologists recommends prescribing low-dose post-coital antibiotics as the primary prevention strategy 2, 3
The Infectious Diseases Society of America suggests using trimethoprim-sulfamethoxazole 160/800 mg as a single dose after intercourse as first-line 2, 3
The European Urology Association recommends nitrofurantoin 50-100 mg post-coitally if local resistance patterns favor it 4

The American Urological Association recommends implementing low-dose daily antibiotic prophylaxis 2, 3
The International Society for the Study of Women's Sexual Health suggests using nitrofurantoin 50-100 mg daily as the preferred agent due to low resistance rates 4

The American Heart Association recommends increasing fluid intake to 1.5-2 liters daily to mechanically flush bacteria from the urinary tract 1
The Academy of Nutrition and Dietetics suggests establishing regular toileting schedules and avoiding prolonged holding of urine 1

The American Urological Association recommends methenamine hippurate 1 gram twice daily as a strong option for women without urinary tract abnormalities 2, 3, 4
The European Urology Association suggests OM-89 (Uro-Vaxom) immunoactive prophylaxis can reduce recurrence across all age groups 1, 4

The American Urological Association recommends that all UTIs in men are considered complicated and require more extensive evaluation than in women 5
The National Institute of Diabetes and Digestive and Kidney Diseases suggests evaluating for urinary tract obstruction, foreign bodies, incomplete bladder emptying, vesicoureteral reflux, and recent instrumentation 5